SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-048410
Filing Date
2010-03-05
Accepted
2010-03-05 07:35:04
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 907592
2 EMPLOYMENT AGREEMENT dex109.htm EX-10.9 69269
3 CERTIFICATE OF AMENDMENTS TO JUNE 2004 COMPENSATORY STOCK OPTION PLAN dex1015.htm EX-10.15 13446
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM MALONEBAILEY, LLP dex23.htm EX-23 2061
5 CERTIFICATION OF CEO AND CFO SECTION 302 dex311.htm EX-31.1 10194
6 CERTIFICATION OF CEO AND CFO SECTION 906 dex321.htm EX-32.1 4730
7 GRAPHIC g88485g70l52.jpg GRAPHIC 6593
  Complete submission text file 0001193125-10-048410.txt   1018239
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 10659006
SIC: 2834 Pharmaceutical Preparations